Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Views - The company turned profitable in Q1 2025, with a net profit of 1.51 billion yuan, marking a significant recovery from previous losses [1][2]. - The overall gross margin improved significantly due to the reduction in inventory costs, with a year-on-year increase of 2.9 percentage points to 27.2% [2]. - The company's cash flow from operating activities showed a net inflow of -2.07 billion yuan, an improvement of 5.28 billion yuan year-on-year, representing the best level since 2019 [2]. Sales Performance - North America saw a 15% year-on-year increase in sales, driven by strong performance in consumer and professional solutions [3]. - Sales in the Asia-Pacific region decreased by 7%, while China experienced an 8% growth due to recovering global demand [3]. - The Latin America region faced a 23% decline in sales, attributed to intensified competition and unfavorable currency exchange rates [3]. Profit Forecast and Valuation - The profit forecast for 2025-2027 has been revised upwards, with expected net profits of 4.17 billion yuan, 7.09 billion yuan, and 10.28 billion yuan respectively [4]. - The report highlights that the improvement in gross margin and cash flow is expected to continue benefiting from the company's operational enhancements and the recovery of certain product prices [4]. - The estimated P/E ratios for 2025, 2026, and 2027 are 35, 20, and 14 respectively, indicating a positive outlook for the company's valuation [5][12].

Core Viewpoint - The company reported a decline in annual revenue for 2024 but showed signs of recovery in the first quarter of 2025, with improved profitability and cost management initiatives yielding positive results [1][2][3] Financial Performance - For the full year 2024, the company achieved revenue of 29.488 billion yuan, a year-over-year decline of 10.0%, and a net loss attributable to shareholders of 2.903 billion yuan [1] - In Q4 2024, the company recorded revenue of 7.965 billion yuan, a quarter-over-quarter increase of 20.4%, but a net loss of 1.065 billion yuan, which increased by 12.9% compared to the previous quarter [1] - In Q1 2025, the company reported revenue of 7.173 billion yuan, a year-over-year decline of 4.5%, but achieved a net profit of 0.151 billion yuan, indicating a turnaround from losses [1] Industry Trends - Some small pesticide varieties have shown signs of price recovery, particularly in insecticides, despite an overall downward trend in pesticide price indices [2] - As of April 27, 2025, the pesticide price index reported a year-over-year decline of 6.1% but a month-over-month increase of 0.29% [2] - The sentiment in the pesticide industry appears to be improving, with expectations for price increases in major herbicides, which could enhance the company's profitability [2] Cost Management and Strategic Initiatives - The company's "Advancement" plan has begun to show results, with a significant reduction in sales expenses and a continuous decline in the sales expense ratio [2] - The company is optimizing cash flow and profitability, which is expected to continue improving in 2025 as expenses are further managed [2] Profit Forecast and Valuation - The net profit forecast for 2025 is maintained at 0.469 billion yuan, with a new forecast for 2026 at 0.627 billion yuan, reflecting a gradual recovery in performance [3] - The target price has been raised by 33.3% to 7.2 yuan, indicating a potential upside of 16.3% from the current stock price, based on improved quarterly performance and sector sentiment [3]

据证券之星公开数据整理，近期安道麦A（000553）发布2025年一季报。根据财报显示，安道麦A净利 润增166.4%，商誉占比较高。截至本报告期末，公司营业总收入71.73亿元，同比下降4.48%，归母净利 润1.51亿元，同比上升166.4%。按单季度数据看，第一季度营业总收入71.73亿元，同比下降4.48%，第 一季度归母净利润1.51亿元，同比上升166.4%。 本次财报公布的各项数据指标表现一般。其中，毛利率27.17%，同比增12.08%，净利率2.11%，同比增 169.51%，销售费用、管理费用、财务费用总计13.46亿元，三费占营收比18.77%，同比减18.45%，每股 净资产8.21元，同比减11.67%，每股经营性现金流-0.09元，同比增71.86%，每股收益0.07元，同比增 166.33% | 项目 | 2024年一季报 | 2025年一季报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 75.09亿 | 71.73亿 | -4.48% | | 归母净利润(元) | -2.28 Z- | 1.51亿 | 166.40% | | ...

Core Viewpoint - AnDuoMai A (000553) has shown a mixed performance in its recent financial results, with a decline in revenue but a significant increase in net profit, indicating potential areas for investment consideration. Trading Information Summary - On April 29, 2025, AnDuoMai A closed at 6.09 yuan, up 6.47%, with a turnover rate of 0.79%, a trading volume of 171,600 shares, and a transaction value of 104 million yuan [1] - The fund flow on the same day showed a net outflow of 4.35 million yuan from main funds, while retail investors contributed a net inflow of 1.40 million yuan [2][7] Shareholder Changes - As of March 31, 2025, the number of shareholders for AnDuoMai A decreased to 29,500, a reduction of 1,832 shareholders or 5.85% since January 27 [3][7] - The average number of shares held per shareholder increased from 72,200 to 73,800, with an average market value of 433,500 yuan per shareholder [3] Performance Disclosure Highlights - In the first quarter of 2025, AnDuoMai A reported a main revenue of 7.173 billion yuan, a year-on-year decrease of 4.48% [4][7] - The net profit attributable to shareholders reached 151 million yuan, a significant increase of 166.4% year-on-year, while the net profit excluding non-recurring items was 102 million yuan, up 140.5% year-on-year [4][7] - The company's debt ratio stood at 62.51%, with investment income of 4.671 million yuan and financial expenses of 22.151 million yuan, alongside a gross profit margin of 27.17% [4]

Core Viewpoint - The agricultural chemical industry is experiencing a recovery in the first quarter of 2024, with most companies reporting improved performance after a period of destocking in 2023 [1][5][6]. Group 1: Company Performance - As of April 28, 29 agricultural chemical companies have disclosed their Q1 reports, with 27 companies reporting profits and 16 showing year-on-year profit growth [1]. - Companies such as Lianhua Technology, Hunan Haili, and Lier Chemical reported net profit increases exceeding 100% year-on-year [2][3]. - Lianhua Technology's Q1 net profit grew over tenfold to 4971.56 million yuan, with a revenue of 15.1 billion yuan, marking a 3.02% increase [2]. - Hunan Haili achieved a revenue of 4.31 billion yuan, up 25.44%, and a net profit of 5661.02 million yuan, up 483.78% [3]. - Lier Chemical reported total revenue of 20.86 billion yuan, a 49.99% increase, and a net profit of 1.53 billion yuan, up 219.9% [3]. - Companies like Xianda Co. and Limin Co. turned losses into profits in Q1 due to increased sales and prices [4]. Group 2: Market Trends - The agricultural chemical market is entering its traditional peak season, with significant destocking observed since the beginning of the year [5][6]. - The market is showing signs of recovery, with an increase in terminal demand and replenishment in both domestic and foreign markets [6]. - The raw material price index for agricultural chemicals rose to 73.11 points, reflecting a 0.29% increase from the previous month [6]. - Industry experts express optimism for 2025, anticipating a stable recovery in the agricultural chemical sector [7].

安道麦股份有限公司 2024年度社会责任报告 Listen > Learn > Deliver 目录 | 统言 | | --- | | 安道麦总裁兼首席执行官奇语 ………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………… 3 | | 关于本报告 | | 关于安道麦. | | 安道寿的可持续发展 … | | 农业创新 | | 环境保护 …………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………… 14 | | 环境管理基础设施 . | | 气候变化与温室气体排放 . | | 能源消耗 - | | 空气质量 | | 水资源使用与废水排放 | | 废弃物管理 | | 土壤与地下水修复… | | 员工与社区… | | 始终倾听员工心声 . | | 公平就业 | | 健康、安全与福利 ……………………………………… ...

安道麦发布 2025 年第一季度业绩 2025 年第一季度净利润扭亏为盈 中国北京及以色列特拉维夫，2025 年 4 月 28 日——安道麦股份有限公司（以下简称"公司"，深证 000553）于今日发布截至 2025 年 3 月 31 日的第一季度财务业绩。 2025 年第一季度财务业绩概要： 安道麦总裁兼首席执行官 Gaël Hili 表示："财务指标中的积极变化增加，令我备受鼓舞。实现正 向增长归因于安道麦正在实施之中的"奋进"转型计划。不仅经营现金流、自由现金流实现改善，调 整后毛利、EBITDA 及其利润率保持增长，2025 年第一季度的净利润也实现了转正。我谨在此祝贺全 体安道麦人为提高运营效率所付出的努力。尽管市场环境仍旧充满挑战，但我乐观坚信，只要我们专 注为投资者与全球各地农民提供长期价值，近期的成果将驱动下一步的成功。" 1 销售额为 10 亿美元，以美元计算同比减少 5%，以人民币计算同比减少 4%，以固定汇率计算同比 减少 3%，同比变化主要体现销量持平，但价格同比下降 4%； 调整后毛利为 3.03 亿美元，同比增加 5%；毛利率提升至 30.3%，2024 年同期为 27.2%，主要 ...

证券代码：000553(200553) 证券简称：安道麦 A（B） 公告编号：2025-21 号 关于为子公司提供担保的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、担保情况概述 为满足安道麦股份有限公司（以下简称"公司"）全资子公司安道麦安邦（江苏） 有限公司（以下简称"安邦"）的日常经营和业务发展资金需要，保证安邦业务顺利开 展，公司拟为安邦2025年度借款事宜，向有关融资银行提供总额不超过人民币16,000万 元的连带责任保证。 此外，为满足公司控股子公司安道麦辉丰（江苏）有限公司（以下简称"安道麦 辉丰"）的生产经营业务发展资金需要，公司拟为安道麦辉丰的用信业务，向银行等 金融机构提供总额不超过人民币15,300万元的连带责任保证。 根据深圳证券交易所股票上市规则等相关规定的要求，公司第十届董事会第十一 次会议审议通过了《关于为子公司提供担保的议案》。本次担保为董事会权限内事宜， 无需提交股东大会审议。 二、被担保人基本情况 1. 安邦的基本情况 安道麦股份有限公司 被担保人名称：安道麦安邦（江苏）有限公司 成立日期：1998 年 11 月 ...

证券代码：000553（200553） 证券简称：安道麦A(B) 公告编号：2025-20号 安道麦股份有限公司 第十届董事会第十一次会议决议公告 会议以 6 票同意，0 票反对，0 票弃权的表决结果审议通过了本议案。 3. 关于为子公司提供担保的议案 公司同意为全资子公司安道麦安邦（江苏）有限公司及控股子公司安道麦辉 丰（江苏）有限公司的用信业务，向相关融资银行等金融机构提供连带责任保证。 1 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 安道麦股份有限公司（以下简称"公司"或"本公司"）第十届董事会第十 一次会议于 2025 年 4 月 24 日通过电子邮件方式通知了所有董事，并于 2025 年 4 月 28 日以视频及现场会议方式召开。会议应出席董事 6 人，实际出席董事 6 人。 本次会议的召开符合有关法律、行政法规、部门规章、规范性法律文件和公 司章程的规定。出席会议的董事审议并通过如下议案： 1. 关于《2025 年第一季度报告》的议案 会议以 6 票同意，0 票反对，0 票弃权的表决结果审议通过了本议案。本议 案具体内容详见同日披露的《2025 ...

Financial Performance - The company's revenue for Q1 2025 was 7,172,735 thousand RMB, a decrease of 4.48% compared to 7,508,899 thousand RMB in the same period last year[6]. - Net profit attributable to shareholders was 151,131 thousand RMB, representing a significant increase of 166.40% from a loss of 227,605 thousand RMB in the previous year[6]. - The company's EBITDA for Q1 2025 was 1,030,712 thousand RMB, reflecting a year-on-year increase of 20.45% from 855,727 thousand RMB[14]. - Q1 2025 gross profit and gross margin improved year-on-year, primarily due to lower costs of newly sold inventory, outweighing negative impacts from price declines and exchange rate fluctuations[19]. - Operating revenue for the current period was 7,172,735 thousand yuan, a decrease of 4.5% compared to 7,508,899 thousand yuan in the previous period[31]. - Net profit for the current period was 151,131 thousand yuan, a significant recovery from a net loss of 227,605 thousand yuan in the previous period[31]. - The company achieved a gross profit margin of approximately 27.2%, up from 24.4% in the previous period[31]. - The total comprehensive income for the current period was 142,621 thousand yuan, compared to a loss of 255,592 thousand yuan in the previous period[31]. - The company’s basic earnings per share improved to 0.065 yuan from a loss of 0.098 yuan per share in the previous period[31]. Cash Flow and Financial Position - The net cash flow from operating activities improved by 71.86%, reaching (206,868) thousand RMB compared to (735,162) thousand RMB in the same period last year[6]. - The company reported a negative cash flow from operating activities of (206,868) thousand yuan, an improvement from (735,162) thousand yuan in the previous period[33]. - Cash and cash equivalents at the end of the period totaled 3,636,561 thousand yuan, slightly down from 3,678,954 thousand yuan in the previous period[33]. - The company experienced a net cash inflow from financing activities of 523,198 thousand yuan, a significant increase from 16,793 thousand yuan in the previous period[33]. - The company's total assets increased by 1.95% to 51,033,738 thousand RMB from 50,059,777 thousand RMB at the end of the previous year[6]. - As of March 31, 2025, total current assets amount to 26,987,991 thousand RMB, an increase from 25,917,390 thousand RMB as of December 31, 2024[30]. - Total current liabilities are reported at 19,103,007 thousand RMB, up from 18,013,457 thousand RMB in the previous period[30]. - Non-current assets total 24,045,747 thousand RMB, slightly down from 24,142,387 thousand RMB[30]. - The company's total liabilities amount to 31,899,093 thousand RMB, an increase from 31,068,683 thousand RMB[30]. - The equity attributable to the parent company totals 19,134,645 thousand RMB, up from 18,991,094 thousand RMB[30]. Market and Sales Performance - Sales in North America increased by 15% to 219 million USD compared to 191 million USD in Q1 2024, while sales in Latin America decreased by 23% to 147 million USD[17]. - North America consumer and professional solutions business sales significantly increased in Q1 2025 compared to the same period in 2024, maintaining strong profit performance[18]. - Brazil's Q1 2025 sales decreased year-on-year due to declining prices and sales, influenced by the weak Brazilian real against the US dollar[18]. - In the Asia-Pacific region, sales outside of China declined year-on-year due to pricing pressure from oversupply of products from China, while sales in China increased year-on-year[18]. - The overall market environment for agricultural products remained challenging, with prices continuing to decline, impacting farmer income and purchasing behavior[11]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 41,269, including 29,480 A-share shareholders and 11,789 B-share shareholders[27]. - The largest shareholder, Syngenta Group Co., Ltd., holds 78.47% of the shares, amounting to 1,828,137,961 shares[27]. - The company has no changes in the shareholding structure of the top 10 shareholders due to securities lending or borrowing[27]. Strategic Initiatives - The "Fengjin" transformation plan was initiated in early 2024, aiming to enhance profits and improve cash flow over three years through financial management optimization, operational restructuring, and deepening value innovation[13]. - Operating expenses in Q1 2025 increased year-on-year due to restructuring and consulting costs related to the "Advancement" transformation plan, with non-operating items impacting reported operating expenses totaling RMB 177 million (USD 25 million)[20]. - There are no significant new strategies or product developments mentioned in the conference call[28]. Other Financial Metrics - The average return on equity was 0.79%, an improvement of 1.84% from (1.04%) in the previous year[6]. - The company reported a total of 49,596 thousand RMB in non-recurring gains, after accounting for tax effects[8]. - Research and development expenses were 103,844 thousand yuan, a decrease of 7.5% from 111,852 thousand yuan in the previous period[31]. - The company reported an increase in investment income to 4,671 thousand yuan from 4,283 thousand yuan in the previous period[31]. - Financial expenses in Q1 2025 decreased to RMB 37.4 million (USD 5.2 million) from RMB 516 million (USD 73 million) in Q1 2024, mainly due to reduced hedging costs and improved cash flow management[21][22]. - The company reported a tax benefit in Q1 2025, primarily due to the appreciation of the Brazilian real against the US dollar affecting the value of non-monetary tax assets[23]. - Derivative financial assets decreased by 85.02% year-on-year to RMB 72.5 million, mainly due to the revaluation of derivative instruments[24]. - Other receivables increased by 66.18% year-on-year to RMB 1.91 billion, primarily due to an asset securitization project[24]. - Derivative financial liabilities increased by 58.30% year-on-year to RMB 440.99 million, also due to the revaluation of derivative instruments[24].